Tikun Olam-Cannbit Pharmaceuticals Ltd

TASE:TKUN 주식 보고서

시가총액: ₪29.2m

Tikun Olam-Cannbit Pharmaceuticals 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Ronen Elad

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기1.3yrs
CEO 소유권5.0%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간4.2yrs

최근 관리 업데이트

Recent updates

Health Check: How Prudently Does Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Use Debt?

Oct 23
Health Check: How Prudently Does Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Use Debt?

Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Has Debt But No Earnings; Should You Worry?

Jun 21
Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Has Debt But No Earnings; Should You Worry?

Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 28
Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Jul 21
Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?

Oct 03
Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?

Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?

Jun 03
Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?

Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt

Oct 17
Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt

Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?

May 19
Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?

Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return

Mar 19
Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return

How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 02
How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?

CEO

Ronen Elad (60 yo)

1.3yrs

테뉴어

Mr. Ronen Elad is Chairman at Tikun Olam-Cannbit Pharmaceuticals Ltd since August 22, 2023 and also serves as its Co-CEO. He serves as the Chairman of Plastopil Hazorea Company Ltd. He is CEO, director and...


이사회 구성원

이름위치테뉴어보상소유권
Ronen Elad
Co-CEO & Chairman1.3yrs데이터 없음5%
₪ 1.5m
Erez Navon
Director5.4yrs데이터 없음2.7%
₪ 787.5k
Yaron Naor
Director5.4yrs데이터 없음10.51%
₪ 3.1m
Yitzhak Ashkenazi
Independent Director5.1yrs데이터 없음0.060%
₪ 17.5k
Ellit Mann Bitton
Independent External Director3.3yrs데이터 없음데이터 없음
Adi Zvulun
Director2.2yrs데이터 없음데이터 없음

4.2yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 이사회: TKUN 의 이사회경험(평균 재직 기간 4.2 년)으로 간주됩니다.